Wound Care Biologics Market

Industry Overview

The Global Wound Care Biologics Market was valued at USD 1.8 billion in 2023, which will grow at a CAGR of 5.7% during the forecast period. Several products such as growth factors, skin substitutes, and collagen-based products majorly contribute to the wound care biologics market size. Increasing geriatric population, increasing the incidence of burn injuries, increasing awareness for wound care management, growing prevalence of ulcer and target conditions are propelling the growth of the market. Wound care biologics offer advanced and innovative solutions for the management of chronic and complex wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical wounds. These biologics can be derived from different sources, such as human placental tissues, amniotic membranes, growth factors, and extracellular matrices.The market for wound care biologics has been growing rapidly in recent years, driven by factors such as an increasing aging population, a rise in chronic wounds and diabetic foot ulcers, and a growing demand for advanced wound care products. These biologics provide several advantages over traditional wound care products, including enhanced wound healing, reduced healing time, decreased infection rates, and improved patient outcomes.

Market Segmentation

Insight by Product

On the basis of product, the global wound care biologics market is categorized into growth factors, skin substitutes, cell-based, collagen-based, enzyme-based, and others. Of all, skin substitutes account for the largest share in the market. The global skin substitutes market is also anticipated to witness significant growth during the forecast period. Growth factors are further categorized into platelet-derived growth factors (PDGF), epidermal growth factors (EGF), insulin-like growth factors (IGF), transforming growth factor-beta (TGF-β), fibroblast growth factors (FGF), and others; whereas skin substitutes are further segmented into acellular animal-derived, human tissue-derived, and biosynthetic. Another category of cell-based products includes viable and non-viable segments.

Insight by Durability

Based on durability, the wound care biologics market is segmented into permanent and temporary biologics. The demand for temporary biologics has witnessed considerable growth over the last few years due to the increasing burn incidences and their lower cost compared to permanent biologics.

Insight by Application

Based on application, the wound care biologics market is segmented into chronic and acute. Among the two categories, chronic would care biologics hold the larger market share due to the growing geriatric population and increasing incidence of pressure ulcers, diabetic foot ulcer and other ulcers.

Insight by End User

Based on end-user, the wound care biologics market is segmented into hospitals and specialty wound care clinics, home healthcare and other end users. The hospital and specialty wound clinics is estimated to account the largest share in the wound care market due to increasing in hospitals and clinics, due to improving healthcare infrastructure in developing countries, increasing number of chronic wound cases and increasing incidence of diabetes.

Global Wound Care Biologics Market Report Coverage

Industry Dynamics

Growth Drivers

Global wound care biologics market has been driven by several key factors, predominantly increasing geriatric population and increasing incidence of burn injuries. Moreover, increasing awareness for wound care management, growing prevalence of ulcer and target conditions across the globe is propelling the demand for wound care biologics. Development of technologically advanced products is also one of the key growth drivers for the global market as conventional methods of wound management are being rapidly replaced by technologically advanced products for effective and faster healing.

Growth Factors: These are proteins that stimulate cell proliferation and tissue regeneration. Examples include platelet-derived growth factors (PDGF), epidermal growth factors (EGF), and transforming growth factors (TGF).

Skin Substitutes: These are biologic or synthetic materials used to replace or augment the skin's function. They can include allografts (human donor skin), xenografts (animal-derived skin), and synthetic grafts.

Extracellular Matrices (ECMs): These are natural or synthetic scaffolds that provide structural support and promote cell migration, proliferation, and tissue remodeling. Examples include collagen-based matrices and hyaluronic acid-based products.

Stem Cells: These are undifferentiated cells that have the potential to differentiate into various cell types. Stem cell therapy is used to promote tissue regeneration and wound healing.

Restraints

The high cost of wound care biologics and stringent regulatory requirements for the approval of products impede the growth of the global wound care biologics market. Moreover, dearth of skilled professionals is also hampering the growth of the wound care biologics market to some extent.

Geography Insight

Geographically, North America is the largest wound care biologics market as the region is home to a large number of industry players. Some of the other factors leading to the growth of the North American market are growing research activities, the highest healthcare expenditure globally, and increasing prevalence of diabetes. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes. The increasing cases of burn cases and increasing investment for research and development are also supporting the growth of the North American market.

Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of largest population and the awareness for wound management is increasing rapidly among them. In addition, government support for wound management is also creating a positive impact on the wound care biologics market growth in the region.

Competitive Insight

Some of the key players operating in the global wound care biologics market are Integra LifeSciences Corporation, MiMedx Group Inc., Wright Medical Group N.V., Osiris Therapeutics Inc., Vericel Corporation, Kerecis Limited, Anika Therapeutics Inc., Acell Inc., Skye Biologics Inc., Solsys Medical, Marine Polymer Technologies Inc., Kerecis Limited, Smith & Nephew plc, and Mölnlycke Health Care AB.

Forecast Parameters
- Identifying variables and establishing market impact.
- Establishing market trends regionally.
- Analyzing opportunities and market penetration rates by understanding product commercialization, regional expansion.
- Analyzing demand and supply trends and changes in industry dynamics to establish future growth.
- Analyzing sustainability strategies adhered by market participants in an attempt to determine future course of the market.
- Analyzing historical market trends and super-imposing them on the current and future variables to determine the year-on-year trend.
- Understanding adoption, production, export, import, and regulatory framework.

Data Validation

- Estimated and forecasted data was validated through industry experts.
- Apart from industry experts, data triangulation methods were used for validation.
- Bottom-up and top-down approach has been used for estimation and forecast of market data, whereas top-down approach was used for validation.
- Demand, as well as supply-side surveys, were conducted in order to understand the industry dynamics and data validation.

Primary Research

VynZ Research conducts extensive primary research to understand the market dynamics, validate market data and have key opinions from the industry experts. The key profiles approached within the industry include CEO, CFO, CTO, President, Vice President, Product Managers, Regional Heads, and Others. Also, end-user surveys comprising of consumers are also conducted to understand consumer behaviour.

The Wound Care Biologics Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Product
  • Growth Factors
    • Platelet-Derived Growth Factors (PDGF)
    • Epidermal Growth Factors (EGF)
    • Insulin-Like Growth Factors (IGF)
    • Transforming Growth Factor-Beta (TGF-β)
    • Fibroblast Growth Factors (FGF)
    • Others
  • Skin Substitutes
    • Acellular Animal-Derived
    • Human Donor-Tissue Derived
    • Biosynthetic
  • Cell-Based
    • Viable
    • Non-viable
      • Collagen-Based
      • Enzyme-Based
      • Others
• By Durability
  • Permanent
  • Temporary
• By Application
  • Chronic
  • Acute
• By End-User
  • Hospitals and Specialty Wound Care Clinics
  • Home Healthcare
  • Others

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

1. Research Overview 

        1.1. The Report Offers
        1.2. Market Coverage
                1.2.1. By Product
                1.2.2. By Durability
                1.2.3. By Application
                1.2.4. By End-User
                1.2.5. By Region
        1.3. Research Phases
        1.4. Limitations
        1.5. Market Size Estimations and Forecast
                1.5.1. Data Sources
                        1.5.1.1. Primary Research
                        1.5.1.2. Secondary Research
                1.5.2. Methodology
                        1.5.2.1. Data Exploration
                        1.5.2.2. Forecast Parameters
                        1.5.2.3. Data Validation
                        1.5.2.4. Assumptions
                1.5.3. Study Period & Data Reporting Unit

2. Executive Summary

3. Market Definition

        3.1. By Product
                3.1.1. Growth Factors
                        3.1.1.1. Platelet-Derived Growth Factors (PDGF)
                        3.1.1.2. Epidermal Growth Factors (EGF)
                        3.1.1.3. Insulin-Like Growth Factors (IGF)
                        3.1.1.4. Transforming Growth Factor-Beta (TGF-β)
                        3.1.1.5. Fibroblast Growth Factors (FGF)
                        3.1.1.6. Others
                3.1.2. Skin Substitutes
                        3.1.2.1. Acellular Animal-Derived
                        3.1.2.2. Human Donor-Tissue Derived
                        3.1.2.3. Biosynthetic
                3.1.3. Cell-Based
                        3.1.3.1. Viable
                        3.1.3.2. Non-viable
                3.1.4. Collagen-Based
                3.1.5. Enzyme-Based
                3.1.6. Others
        3.2. By Durability
                3.2.1. Permanent
                3.2.2. Temporary
        3.3. By Application
                3.3.1. Chronic
                3.3.2. Acute
        3.4. By End-User
                3.4.1. Hospitals and Specialty Wound Care Clinics
                3.4.2. Home Healthcare
                3.4.3. Others 

4. Industry Overview

        4.1. Industry Dynamics
                4.1.1. Major Drivers
                4.1.2. Major Restraints
                4.1.3. Key Trends
                4.1.4. Key Opportunities
        4.2. Industry Ecosystem
                4.2.1. Porter’s Five Forces Analysis
                4.2.2. Strategic Development Analysis
        4.3. Competitive Insight
                4.3.1. Competitive Analysis of Key Players
                4.3.2. Market Attractiveness Analysis

5. Global Market Estimate and Forecast

        5.1. By Product
        5.2. By Durability
        5.3. By Application
        5.4. By End-User
        5.5. By Region

6. North America Market Estimate and Forecast

        6.1. By Product
        6.2. By Durability
        6.3. By Application
        6.4. By End-User
        6.5. By Country
                6.5.1. U.S. Market Estimate and Forecast
                6.5.2. Canada Market Estimate and Forecast
                6.5.3. Mexico Market Estimate and Forecast

7. Europe Market Estimate and Forecast

        7.1. By Product
        7.2. By Durability
        7.3. By Application
        7.4. By End-User
        7.5. By Country
                7.5.1. Germany Market Estimate and Forecast
                7.5.2. U.K. Market Estimate and Forecast
                7.5.3. France Market Estimate and Forecast
                7.5.4. Italy Market Estimate and Forecast
                7.5.5. Spain Market Estimate and Forecast
                7.5.6. Rest of Europe Market Estimate and Forecast

8. Asia-Pacific Market Estimate and Forecast

        8.1. By Product
        8.2. By Durability
        8.3. By Application
        8.4. By End-User
        8.5. By Country
                8.5.1. Japan Market Estimate and Forecast
                8.5.2. China Market Estimate and Forecast
                8.5.3. India Market Estimate and Forecast
                8.5.4. Australia Market Estimate and Forecast
                8.5.5. South Korea Market Estimate and Forecast
                8.5.6. Rest of Asia-Pacific Market Estimate and Forecast

9. Rest of the World Market Estimate and Forecast

        9.1. By Product
        9.2. By Durability
        9.3. By Application
        9.4. By End-User
        9.5. By Country
                9.5.1. Brazil Market Estimate and Forecast
                9.5.2. Saudi Arabia Market Estimate and Forecast
                9.5.3. U.A.E. Market Estimate and Forecast
                9.5.4. South Africa Market Estimate and Forecast
                9.5.5. Other Countries Market Estimate and Forecast

10. Company Profiles

        10.1. Integra LifeSciences Corporation
                10.1.1. Snapshot
                10.1.2. Overview
                10.1.3. Offerings
                10.1.4. Financial Insight
                10.1.5. Recent Developments
        10.2. MiMedx Group Inc.
                10.2.1. Snapshot
                10.2.2. Overview
                10.2.3. Offerings
                10.2.4. Financial Insight
                10.2.5. Recent Developments
        10.3. Wright Medical Group N.V.
                10.3.1. Snapshot
                10.3.2. Overview
                10.3.3. Offerings
                10.3.4. Financial Insight
                10.3.5. Recent Developments
        10.4. Osiris Therapeutics Inc.
                10.4.1. Snapshot
                10.4.2. Overview
                10.4.3. Offerings
                10.4.4. Financial Insight
                10.4.5. Recent Developments
        10.5. Vericel Corporation
                10.5.1. Snapshot
                10.5.2. Overview
                10.5.3. Offerings
                10.5.4. Financial Insight
                10.5.5. Recent Developments
        10.6. Kerecis Limited
                10.6.1. Snapshot
                10.6.2. Overview
                10.6.3. Offerings
                10.6.4. Financial Insight
                10.6.5. Recent Developments
        10.7. Anika Therapeutics Inc.
                10.7.1. Snapshot
                10.7.2. Overview
                10.7.3. Offerings
                10.7.4. Financial Insight
                10.7.5. Recent Developments
        10.8. Acell Inc.
                10.8.1. Snapshot
                10.8.2. Overview
                10.8.3. Offerings
                10.8.4. Financial Insight
                10.8.5. Recent Developments
        10.9. Skye Biologics Inc.
                10.9.1. Snapshot
                10.9.2. Overview
                10.9.3. Offerings
                10.9.4. Financial Insight
                10.9.5. Recent Developments
        10.10. Solsys Medical
                10.10.1. Snapshot
                10.10.2. Overview
                10.10.3. Offerings
                10.10.4. Financial Insight
                10.10.5. Recent Developments
        10.11. Marine Polymer Technologies Inc.
                10.11.1. Snapshot
                10.11.2. Overview
                10.11.3. Offerings
                10.11.4. Financial Insight
                10.11.5. Recent Developments
        10.12. Kerecis Limited
                10.12.1. Snapshot
                10.12.2. Overview
                10.12.3. Offerings
                10.12.4. Financial Insight
                10.12.5. Recent Developments
        10.13. Smith & Nephew plc
                10.13.1. Snapshot
                10.13.2. Overview
                10.13.3. Offerings
                10.13.4. Financial Insight
                10.13.5. Recent Developments
        10.14. Mölnlycke Health Care AB
                10.14.1. Snapshot
                10.14.2. Overview
                10.14.3. Offerings
                10.14.4. Financial Insight
                10.14.5. Recent Developments

* Financial insight, are subject to availability of information in secondary domain.

11. Appendix

        11.1. Exchange Rates
        11.2. Abbreviations

List of Tables

Table 1  Sources
Table 2  Study Periods
Table 3  Data Reporting Unit
Table 4  Global Wound Care Biologics Market Size, by Product, 2018 - 2023 (USD Billion)
Table 5  Global Wound Care Biologics Market Size, by Product, 2025 - 2030 (USD Billion)
Table 6  Global Wound Care Growth Factors Market Size, by Type, 2018 - 2023 (USD Billion)
Table 7  Global Wound Care Growth Factors Market Size, by Type, 2025 - 2030 (USD Billion)
Table 8  Global Wound Care Skin Substitutes Market Size, by Type, 2018 - 2023 (USD Billion)
Table 9  Global Wound Care Skin Substitutes Market Size, by Type, 2025 - 2030 (USD Billion)
Table 10  Global Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2023 (USD Billion)
Table 11  Global Cell-Based Wound Care Biologics Market Size, by Type, 2025 - 2030 (USD Billion)
Table 12  Global Wound Care Biologics Market Size, by Durability, 2018 - 2023 (USD Billion)
Table 13  Global Wound Care Biologics Market Size, by Durability, 2025 - 2030 (USD Billion)
Table 14  Global Wound Care Biologics Market Size, by Application, 2018 - 2023 (USD Billion)
Table 15  Global Wound Care Biologics Market Size, by Application, 2025 - 2030 (USD Billion)
Table 16  Global Wound Care Biologics Market Size, by End-User, 2018 - 2023 (USD Billion)
Table 17  Global Wound Care Biologics Market Size, by End-User, 2025 - 2030 (USD Billion)
Table 18  Global Wound Care Biologics Market Size, by Region, 2018 - 2023 (USD Billion)
Table 19  Global Wound Care Biologics Market Size, by Region, 2025 - 2030 (USD Billion)
Table 20  North America Wound Care Biologics Market Size, by Product, 2018 - 2023 (USD Billion)
Table 21  North America Wound Care Biologics Market Size, by Product, 2025 - 2030 (USD Billion)
Table 22  North America Wound Care Growth Factors Market Size, by Type, 2018 - 2023 (USD Billion)
Table 23  North America Wound Care Growth Factors Market Size, by Type, 2025 - 2030 (USD Billion)
Table 24  North America Wound Care Skin Substitutes Market Size, by Type, 2018 - 2023 (USD Billion)
Table 25  North America Wound Care Skin Substitutes Market Size, by Type, 2025 - 2030 (USD Billion)
Table 26  North America Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2023 (USD Billion)
Table 27  North America Cell-Based Wound Care Biologics Market Size, by Type, 2025 - 2030 (USD Billion)
Table 28  North America Wound Care Biologics Market Size, by Durability, 2018 - 2023 (USD Billion)
Table 29  North America Wound Care Biologics Market Size, by Durability, 2025 - 2030 (USD Billion)
Table 30  North America Wound Care Biologics Market Size, by Application, 2018 - 2023 (USD Billion)
Table 31  North America Wound Care Biologics Market Size, by Application, 2025 - 2030 (USD Billion)
Table 32  North America Wound Care Biologics Market Size, by End-User, 2018 - 2023 (USD Billion)
Table 33  North America Wound Care Biologics Market Size, by End-User, 2025 - 2030 (USD Billion)
Table 34  North America Wound Care Biologics Market Size, by Country, 2018 - 2023 (USD Billion)
Table 35  North America Wound Care Biologics Market Size, by Country, 2025 - 2030 (USD Billion)
Table 36  Europe Wound Care Biologics Market Size, by Product, 2018 - 2023 (USD Billion)
Table 37  Europe Wound Care Biologics Market Size, by Product, 2025 - 2030 (USD Billion)
Table 38  Europe Wound Care Growth Factors Market Size, by Type, 2018 - 2023 (USD Billion)
Table 39  Europe Wound Care Growth Factors Market Size, by Type, 2025 - 2030 (USD Billion)
Table 40  Europe Wound Care Skin Substitutes Market Size, by Type, 2018 - 2023 (USD Billion)
Table 41  Europe Wound Care Skin Substitutes Market Size, by Type, 2025 - 2030 (USD Billion)
Table 42  Europe Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2023 (USD Billion)
Table 43  Europe Cell-Based Wound Care Biologics Market Size, by Type, 2025 - 2030 (USD Billion)
Table 44  Europe Wound Care Biologics Market Size, by Durability, 2018 - 2023 (USD Billion)
Table 45  Europe Wound Care Biologics Market Size, by Durability, 2025 - 2030 (USD Billion)
Table 46  Europe Wound Care Biologics Market Size, by Application, 2018 - 2023 (USD Billion)
Table 47  Europe Wound Care Biologics Market Size, by Application, 2025 - 2030 (USD Billion)
Table 48  Europe Wound Care Biologics Market Size, by End-User, 2018 - 2023 (USD Billion)
Table 49  Europe Wound Care Biologics Market Size, by End-User, 2025 - 2030 (USD Billion)
Table 50  Europe Wound Care Biologics Market Size, by Country, 2018 - 2023 (USD Billion)
Table 51  Europe Wound Care Biologics Market Size, by Country, 2025 - 2030 (USD Billion)
Table 52  Asia-Pacific Wound Care Biologics Market Size, by Product, 2018 - 2023 (USD Billion)
Table 53  Asia-Pacific Wound Care Biologics Market Size, by Product, 2025 - 2030 (USD Billion)
Table 54  Asia-Pacific Wound Care Growth Factors Market Size, by Type, 2018 - 2023 (USD Billion)
Table 55  Asia-Pacific Wound Care Growth Factors Market Size, by Type, 2025 - 2030 (USD Billion)
Table 56  Asia-Pacific Wound Care Skin Substitutes Market Size, by Type, 2018 - 2023 (USD Billion)
Table 57  Asia-Pacific Wound Care Skin Substitutes Market Size, by Type, 2025 - 2030 (USD Billion)
Table 58  Asia-Pacific Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2023 (USD Billion)
Table 59  Asia-Pacific Cell-Based Wound Care Biologics Market Size, by Type, 2025 - 2030 (USD Billion)
Table 60  Asia-Pacific Wound Care Biologics Market Size, by Durability, 2018 - 2023 (USD Billion)
Table 61  Asia-Pacific Wound Care Biologics Market Size, by Durability, 2025 - 2030 (USD Billion)
Table 62  Asia-Pacific Wound Care Biologics Market Size, by Application, 2018 - 2023 (USD Billion)
Table 63  Asia-Pacific Wound Care Biologics Market Size, by Application, 2025 - 2030 (USD Billion)
Table 64  Asia-Pacific Wound Care Biologics Market Size, by End-User, 2018 - 2023 (USD Billion)
Table 65  Asia-Pacific Wound Care Biologics Market Size, by End-User, 2025 - 2030 (USD Billion)
Table 66  Asia-Pacific Wound Care Biologics Market Size, by Country, 2018 - 2023 (USD Billion)
Table 67  Asia-Pacific Wound Care Biologics Market Size, by Country, 2025 - 2030 (USD Billion)
Table 68  RoW Wound Care Biologics Market Size, by Product, 2018 - 2023 (USD Billion)
Table 69  RoW Wound Care Biologics Market Size, by Product, 2025 - 2030 (USD Billion)
Table 70  RoW Wound Care Growth Factors Market Size, by Type, 2018 - 2023 (USD Billion)
Table 71  RoW Wound Care Growth Factors Market Size, by Type, 2025 - 2030 (USD Billion)
Table 72  RoW Wound Care Skin Substitutes Market Size, by Type, 2018 - 2023 (USD Billion)
Table 73  RoW Wound Care Skin Substitutes Market Size, by Type, 2025 - 2030 (USD Billion)
Table 74  RoW Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2023 (USD Billion)
Table 75  RoW Cell-Based Wound Care Biologics Market Size, by Type, 2025 - 2030 (USD Billion)
Table 76  RoW Wound Care Biologics Market Size, by Durability, 2018 - 2023 (USD Billion)
Table 77  RoW Wound Care Biologics Market Size, by Durability, 2025 - 2030 (USD Billion)
Table 78  RoW Wound Care Biologics Market Size, by Application, 2018 - 2023 (USD Billion)
Table 79  RoW Wound Care Biologics Market Size, by Application, 2025 - 2030 (USD Billion)
Table 80  RoW Wound Care Biologics Market Size, by End-User, 2018 - 2023 (USD Billion)
Table 81  RoW Wound Care Biologics Market Size, by End-User, 2025 - 2030 (USD Billion)
Table 82  RoW Wound Care Biologics Market Size, by Country, 2018 - 2023 (USD Billion)
Table 83  RoW Wound Care Biologics Market Size, by Country, 2025 - 2030 (USD Billion)
Table 84  Snapshot – Integra LifeSciences Corporation
Table 85  Snapshot – MiMedx Group Inc.
Table 86  Snapshot – Wright Medical Group N.V.
Table 87  Snapshot – Osiris Therapeutics Inc.
Table 88  Snapshot – Vericel Corporation
Table 89  Snapshot – Kerecis Limited
Table 90  Snapshot – Anika Therapeutics Inc
Table 91  Snapshot – Acell Inc.
Table 92  Snapshot – Skye Biologics Inc.
Table 93  Snapshot – Solsys Medical.
Table 94  Snapshot – Marine Polymer Technologies Inc.
Table 95  Snapshot – Kerecis Limited
Table 96  Snapshot – Smith & Nephew plc
Table 97  Snapshot – Mölnlycke Health Care AB

List of Figures

Figure 1  Market Coverage
Figure 2  Research Phases
Figure 3  Secondary Products for Different Parameters
Figure 4  Methodology
Figure 5  Data Mining & Exploration
Figure 6  Data Triangulation
Figure 7  Assumptions for Market Estimation and Forecast
Figure 8  Market Synopsis
Figure 9  Global Wound Care Biologics Market - Growth Drivers and Restraints
Figure 10  Competitive Benchmark
Figure 11  Global Wound Care Biologics Market Highlight
Figure 12  Global Wound Care Biologics Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 13  Global Wound Care Growth Factors Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 14  Global Wound Care Skin Substitutes Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 15  Global Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 16  Global Wound Care Biologics Market Size, by Durability, 2018 - 2030 (USD Billion)
Figure 17  Global Wound Care Biologics Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 18  Global Wound Care Biologics Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 19  Global Wound Care Biologics Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 20  North America Wound Care Biologics Market Highlight
Figure 21  North America Wound Care Biologics Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 22  North America Wound Care Growth Factors Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 23  North America Wound Care Skin Substitutes Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 24  North America Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 25  North America Wound Care Biologics Market Size, by Durability, 2018 - 2030 (USD Billion)
Figure 26  North America Wound Care Biologics Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 27  North America Wound Care Biologics Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 28  North America Wound Care Biologics Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 29  Europe Wound Care Biologics Market Highlight
Figure 30  Europe Wound Care Biologics Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 31  Europe Wound Care Growth Factors Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 32  Europe Wound Care Skin Substitutes Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 33  Europe Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 34  Europe Wound Care Biologics Market Size, by Durability, 2018 - 2030 (USD Billion)
Figure 35  Europe Wound Care Biologics Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 36  Europe Wound Care Biologics Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 37  Europe Wound Care Biologics Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 38  Asia-Pacific Wound Care Biologics Market Highlight
Figure 39  Asia-Pacific Wound Care Biologics Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 40  Asia-Pacific Wound Care Growth Factors Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 41  Asia-Pacific Wound Care Skin Substitutes Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 42  Asia-Pacific Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 43  Asia-Pacific Wound Care Biologics Market Size, by Durability, 2018 - 2030 (USD Billion)
Figure 44  Asia-Pacific Wound Care Biologics Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 45  Asia-Pacific Wound Care Biologics Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 46  Asia-Pacific Wound Care Biologics Market Size, by Country, 2018 - 2030 (USD Billion)
Figure 47  RoW Wound Care Biologics Market Highlight
Figure 48  RoW Wound Care Biologics Market Size, by Product, 2018 - 2030 (USD Billion)
Figure 49  RoW Wound Care Growth Factors Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 50  RoW Wound Care Skin Substitutes Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 51  RoW Cell-Based Wound Care Biologics Market Size, by Type, 2018 - 2030 (USD Billion)
Figure 52  RoW Wound Care Biologics Market Size, by Durability, 2018 - 2030 (USD Billion)
Figure 53  RoW Wound Care Biologics Market Size, by Application, 2018 - 2030 (USD Billion)
Figure 54  RoW Wound Care Biologics Market Size, by End-User, 2018 - 2030 (USD Billion)
Figure 55  RoW Wound Care Biologics Market Size, by Country, 2018 - 2030 (USD Billion)